In the case of TANs, studies have shown that a high neutrophil-to-lymphocyte ratio in peripheral blood is prognostic of worse overall survival and disease-free survival for breast cancers, especially ones that are ER- and HER2-negative [77]. This evidence concerns the gene ERBB2 and breast cancer.